Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine

• SHIMASAKI Takeo

  Department of Medical Oncology, Kanazawa Medical University

• ISHIGAKI Yasuhito

  Medical Research Institute, Kanazawa Medical University

• NAKAMURA Yuka

  Medical Research Institute, Kanazawa Medical University

• TAKATA Takanobu

  Medical Research Institute, Kanazawa Medical University

• NAKAYA Naoki

  Department of Medical Oncology, Kanazawa Medical University

• NAKAJIMA Hideo

  Department of Medical Oncology, Kanazawa Medical University

• SATO Itaru

  Department of Medical Oncology, Kanazawa Medical University

• ZHAO Xia

  Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

• KITANO Ayako

  Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University

• KAWAKAMI Kazuyuki

  Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University

• TANAKA Takuji

  Department of Pathology, Kanazawa Medical University

• TAKEGAMI Tsutomu

  Medical Research Institute, Kanazawa Medical University

• TOMOSUGI Naohisa

  Medical Research Institute, Kanazawa Medical University

• MINAMOTO Toshinari

  Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University

• MOTOO Yoshiharu

  Department of Medical Oncology, Kanazawa Medical University

Journal

• Journal of gastroenterology

  Journal of gastroenterology 47 (3), 321-333, 2012-03-01

Keywords

• Pancreatic cancer
• Gemcitabine
• Glycogen synthase kinase 3β
• TP53INP1

Details

• CRID: 1573387450553150976
• NII Article ID: 10030560208
• NII Book ID: AA10988015
• ISSN: 09441174
• Web Site: https://search.jamas.or.jp/link/ui/2013106593
• Text Lang: en
• Data Source:
  • CiNii Articles